Oramed Pharmaceuticals, Inc. (ORMP)
5.26
+0.05
(+0.96%)
USD |
NASDAQ |
Aug 26, 09:34
Oramed Pharmaceuticals EPS Diluted (Quarterly) : 1.839 for June 30, 2026
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical EPS Diluted (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 1.839 |
| March 31, 2026 | 0.9128 |
| December 31, 2025 | 0.2274 |
| September 30, 2025 | 1.131 |
| June 30, 2025 | 0.3119 |
| March 31, 2025 | -0.1854 |
| December 31, 2024 | -0.2552 |
| September 30, 2024 | -0.4797 |
| June 30, 2024 | 0.2215 |
| March 31, 2024 | 0.037 |
| December 31, 2023 | 0.3303 |
| September 30, 2023 | -0.0797 |
| June 30, 2023 | -0.0297 |
| March 31, 2023 | -0.0848 |
| December 31, 2022 | -0.2164 |
| September 30, 2022 | -0.1806 |
| June 30, 2022 | -0.2715 |
| March 31, 2022 | -0.2695 |
| August 31, 2021 | -0.2092 |
| May 31, 2021 | -0.174 |
| February 28, 2021 | -0.1706 |
| November 30, 2020 | -0.2346 |
| August 31, 2020 | -0.1265 |
| May 31, 2020 | -0.0984 |
| February 29, 2020 | -0.207 |
| Date | Value |
|---|---|
| November 30, 2019 | -0.1455 |
| August 31, 2019 | -0.1312 |
| May 31, 2019 | -0.2333 |
| February 28, 2019 | -0.212 |
| November 30, 2018 | -0.2465 |
| August 31, 2018 | -0.18 |
| May 31, 2018 | -0.30 |
| February 28, 2018 | -0.20 |
| November 30, 2017 | -0.18 |
| August 31, 2017 | -0.20 |
| May 31, 2017 | -0.15 |
| February 28, 2017 | -0.24 |
| November 30, 2016 | -0.20 |
| August 31, 2016 | -0.36 |
| May 31, 2016 | -0.15 |
| February 29, 2016 | -0.14 |
| November 30, 2015 | -0.21 |
| August 31, 2015 | -0.19 |
| May 31, 2015 | -0.15 |
| February 28, 2015 | -0.15 |
| November 30, 2014 | -0.19 |
| August 31, 2014 | -0.16 |
| May 31, 2014 | -0.18 |
| February 28, 2014 | -0.12 |
| November 30, 2013 | -0.14 |
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Eli Lilly & Co. | 7.939 |
| Pfizer Inc. | -0.0435 |
| Yarrow Bioscience, Inc. | -3.504 |
| Liquidia Corp. | 0.7369 |
| NRX Pharmaceuticals, Inc. | -0.4388 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | 78.16M |
| Total Expenses (Quarterly) | -78.16M |
| Enterprise Value | 165.37M |
| Earnings Yield | 78.15% |
| Normalized Earnings Yield | 19.93 |